Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type [NA]
This clinical trial update covers an efficacy study of abdominal massage therapy for Generalized Anxiety Disorder (deficiency of heart and s…
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector [Phase 1]
Phase 1 trial results for a cognitive-behavioral therapy program addressing generalized anxiety disorder in Latino patients in general medic…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Quetiapine in Co-Morbid Depressive and Anxiety Disorders [NA]
A completed clinical trial evaluating quetiapine for co-morbid depressive and anxiety disorders, including major depressive disorder, dysthy…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder [Phase 4]
This is an open-label Phase 4 trial evaluating duloxetine for irritable bowel syndrome with comorbid generalized anxiety disorder. The study…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) [Phase 2]
Phase 2 clinical trial update for SPD503 in children and adolescents with generalized anxiety disorder, separation anxiety disorder, or soci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder [Phase 3]
This document reports a Phase 3 trial evaluating the efficacy and safety of Gabitril (tiagabine) in adults with generalized anxiety disorder…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. [Phase 3]
A Phase 3 study evaluating the safety and efficacy of GABITRIL for adults with Generalized Anxiety Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of Gabitril (tiagabine) in adults with generalized anxiety disorder has complete…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder [Phase 3]
This clinical trial update reports the completion of a Phase 3 10-week efficacy and safety study of Gabitril (tiagabine) in adults with Gene…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder [Phase 4]
Phase 4 trial evaluating the combination of Paroxetine CR and Quetiapine for refractory generalized anxiety disorder; results were posted af…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder [Phase 4]
A Phase 4 trial of ziprasidone for generalized anxiety disorder in patients with bipolar disorder was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS [Phase 3]
Phase 3 study evaluating escitalopram (Lexapro) for generalized anxiety disorder in patients with HIV infection has completed, with results …
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders [NA]
This clinical trial update reports the completion of a randomized study evaluating a brief, transdiagnostic therapy called False Safety Beha…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: A Study in Pediatric Participants With Generalized Anxiety Disorder [Phase 3]
A Phase 3 pediatric study for generalized anxiety disorder has completed, with results posted in March 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of vortioxetine for generalized anxiety disorder in adults; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder [Phase 3]
A Phase 3 trial of quetiapine extended-release for major depressive disorder with comorbid generalized anxiety disorder was terminated, and …
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating the efficacy of vortioxetine for generalized anxiety disorder; results were posted in December 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder [Phase 3]
This update reports results from a Phase 3 efficacy and safety study of vortioxetine for generalized anxiety disorder. The trial has complet…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder [Phase 3]
A Phase 3 trial evaluating vortioxetine (Lu AA21004) for generalized anxiety disorder has completed, with results posted in 2013. The update…
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Lorazepam-Induced Toxicity in the Aged [Phase 4]
Phase 4 clinical trial update highlighting lorazepam-associated toxicity in older adults, raising safety considerations for patients with an…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence [NA]
A completed clinical trial update examining the prevalence of common mental disorders in individuals with long-term sickness absence and the…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Muscle Relaxation Therapy With Odorant Cue [NA]
A completed clinical trial from Emory University evaluated muscle relaxation therapy using an odorant cue for generalized anxiety disorder a…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD) [Phase 3]
Phase 3 trial evaluating quetiapine extended-release (XR) for bipolar disorder patients with comorbid generalized anxiety disorder; results …
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: A Study of Duloxetine in Elderly Generalized Anxiety Disorder [Phase 4]
Phase 4 study evaluating duloxetine in elderly patients with Generalized Anxiety Disorder completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Lifestyle Interventions for Generalized Anxiety Disorder [NA]
A clinical trial evaluating lifestyle interventions for Generalized anxiety disorder, including aerobic exercise and stretching, has been te…